Company Valuation: American Oncology Network, Inc.

Data adjusted to current consolidation scope
Fiscal Period: December 2021 2022 2023 2024
Market Cap 1 - - 56.35 137.1
Change - - - 143.33%
Enterprise Value (EV) - - 125.3 215.2
Change - - - 71.77%
P/E - - -4.32x -5.7x
PBR - - -0.35x -3.31x
PEG - - - 0.2x
Capitalization / Revenue - - 0.04x 0.08x
EV / Revenue - - 0x 0x
EV / EBITDA - - -0x -0x
EV / EBIT - - -0x -0x
EV / FCF - - - -
FCF Yield - - - -
Dividend per Share 2 - - - -
Rate of return - - - -
EPS 2 - - -1.365 -0.8874
Distribution rate - - - -
Net sales 1 943.7 1,150 1,279 1,759
EBITDA 1 6.99 12.28 -4.668 -5.575
EBIT 1 0.911 5.566 -13.12 -16.09
Net income 1 -0.105 2.589 -5.542 -3.973
Net Debt 36.34 91.97 68.94 78.1
Reference price 2 9.75 10.04 5.90 5.06
Nbr of stocks (in thousands) - - 9,550 27,096
Announcement Date 1/6/23 4/28/23 3/28/24 3/27/25
1USD in Million2USD
Estimates


P/E (Y) EV / Sales (Y) EV / EBITDA (Y) Dividend Yield (Y) Capi.($)
- - - - 746M
11.65x0.37x7.72x3.33% 102B
16.87x1.99x9.9x0.61% 107B
-272.43x18.99x-321.12x-.--% 56.36B
15.57x1.66x10.02x2.27% 32.48B
27.25x2.37x13.42x0.79% 29.86B
24.77x2.74x13.91x1.29% 28.13B
8.03x1.51x6.67x-.--% 23.26B
29.44x5.26x21.55x2.37% 19.9B
30.11x2.84x12.79x1.47% 16.92B
Average -12.08x 4.19x -25.02x 1.35% 41.66B
Weighted average by Cap. -21.80x 4.11x -34.47x 1.47%

Y-o-Y evolution of P/E

Valuation ratios - P/E - American Oncology Network, Inc.

Historical PBR trend

Valuation ratios - PBR - American Oncology Network, Inc.

Evolution Enterprise Value / Sales

Valuation ratios - VE_REV - American Oncology Network, Inc.

Change in Enterprise Value/EBITDA

Valuation ratios - VE_EBITDA - American Oncology Network, Inc.

  1. Stock Market
  2. Stocks
  3. AONC Stock
  4. Valuation American Oncology Network, Inc.